Your shopping cart is currently empty

IV-361, an orally active and selective CDK7 inhibitor with a Ki value of less than or equal to 50 nM, demonstrates potent anti-cancer activity (US20190256531A1).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $871 | Inquiry | Inquiry | |
| 10 mg | $1,360 | Inquiry | Inquiry |
| Description | IV-361, an orally active and selective CDK7 inhibitor with a Ki value of less than or equal to 50 nM, demonstrates potent anti-cancer activity (US20190256531A1). |
| Targets&IC50 | CDK2:≥1000 nM (Ki), CDK7:≤50 nM (Ki) |
| In vitro | IV-361 demonstrates minimal inhibitory effects on CDK2 (K i ≥1000 nM) and PLK1 (K i ≥5000 nM), highlighting its specificity[1]. Moreover, it exhibits potent inhibition of IL-2 and IL-17 production (all IC 50 ≤100 nM) in peripheral blood mononuclear cells (PBMC), alongside significant growth inhibitory activity against HCT-116 cells (GI 50 ≤100 nM)[1]. |
| In vivo | IV-361, administered orally at a dosage of 25 mg/kg/day, demonstrates a suppression rate of 46% or greater in tumor volume in female BALB/c nude mice implanted with HCT-116[1]. |
| Molecular Weight | 457.625 |
| Formula | C23H32FN5O2Si |
| Cas No. | 2055741-39-2 |
| Smiles | Cc1ccc(F)cc1NC(=O)N1Cc2c(NC(=O)C3(CCC3)[Si](C)(C)C)n[nH]c2C1(C)C |
| Relative Density. | 1.24 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.